Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Medical Oncology

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-011-0133-4PMID 22167391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells.

  2011cited by this paper
• Simultaneous isolation of DNA, RNA, and protein from Medicago truncatula L.

  2011cited by this paper
• Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.

  2011cited by this paper
• High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

  2010cited by this paper
• Low expression of Mel-18 predicts poor prognosis in patients with breast cancer.

  2010cited by this paper
• Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma

  2009cited by this paper
• Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma

  2009cited by this paper
• Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma

  2009cited by this paper
• Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma

  2008cited by this paper
• Definitive chemoradiation in the management of locally advanced esophageal cancer.

  2007cited by this paper
• Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers

  2007cited by this paper
• Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

  2006cited by this paper
• Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

  2006cited by this paper
• Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

  2006cited by this paper
• Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.

  2006cited by this paper
• Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus

  2005cited by this paper
• Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3

  2004cited by this paper
• Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells.

  2003cited by this paper
• Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma.

  2002cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.

  2002cited by this paper
• IGFBP-3 and apoptosis—a licence to kill?

  2001cited by this paper
• IGFBp‐3 prolongs the p53 response and enhances apoptosis following UV irradiation

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.

  2000cited by this paper
• Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells*

  2000cited by this paper
• Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3.

  2000cited by this paper
• Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus

  1999cited by this paper
• The insulin-like growth factor-binding protein (IGFBP) superfamily.

  1999cited by this paper
• Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner*

  1997cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper

• Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma

  2023cites this paper
• Exosomes-derived miR-154-5p attenuates esophageal squamous cell carcinoma progression and angiogenesis by targeting kinesin family member 14

  2022cites this paper
• IGFBP‐3 and TGF‐β inhibit growth in epithelial cells by stimulating type V TGF‐β receptor (TβR‐V)‐mediated tumor suppressor signaling

  2021cites this paper
• The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer

  2020cites this paper
• Uncovering the Mechanism of the Effects of Pien-Tze-Huang on Liver Cancer Using Network Pharmacology and Molecular Docking

  2020cites this paper
• Clinical significance of serum IGFBP‐3 in colorectal cancer

  2019cites this paper
• Cellular and molecular signature of oral squamous cell carcinoma

  2018cites this paper
• Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma

  2017cites this paper
• Correlation between insulin-like growth factor binding protein 3 and metastasis-associated gene 1 protein in esophageal squamous cell carcinoma

  2016cites this paper
• The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis

  2016influential citation
• IGFBP 3 polymorphisms and risk of esophageal cancer in a Chinese population

  2015cites this paper
• Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers

  2015cites this paper
• IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.

  2015cites this paper
• Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

  2015cites this paper
• Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma.

  2015cites this paper
• Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma

  2015cites this paper
• IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment.

  2014cites this paper
• Insulin-like growth factor binding protein-3 (IGFBP-3) genetic variant and the risk of esophageal squamous cell carcinoma in a Chinese population.

  2014cites this paper
• ROLE OF ENDOGENOUS IGFBP-3 IN MAMMARY EPITHELIAL CELL APOPTOSIS

  2014cites this paper
• Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer

  2014cites this paper
• Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma

  2012cites this paper